EXHIBIT 10.33
AMENDMENT AGREEMENT
between
SmithKline Xxxxxxx Corporation
and
NPS Pharmaceuticals, Inc.
dated October 27, 1997.
27 October 97
NPS Pharmaceuticals, Inc.
000 Xxxxxxx Xxx
Xxxx Xxxx Xxxx, Xxxx 00000
RE: Amendment Agreement
Dear Sirs:
This Amendment Agreement (hereinafter "Amendment Agreement") will confirm
that the Letter Agreement dated October 28, 1996 between NPS Pharmaceuticals,
Inc., a corporation of the state of Delaware, having a place of business at 000
Xxxxxxx Xxx, Xxxx Xxxx Xxxx, Xxxx 00000, X.X.X. (herein referred to as "NPS")
and SmithKline Xxxxxxx Corporation, a corporation of the Commonwealth of
Pennsylvania, having a place of business at Xxx Xxxxxxxx Xxxxx, Xxxxxxxxxxxx,
Xxxxxxxxxxxx 00000, X.X.X. (hereinafter referred to as "SB") shall be amended,
effective as of the date of NPS' signature below, as follows:
. In Paragraph 2.01, delete the words "four (4) years" and replace them with
the words "forty nine (49) months";
. All other terms and conditions of the Letter Agreement shall remain in full
force and effect.
Please indicate your acceptance of this Amendment Agreement by signing and
dating the duplicate copies of this letter below and returning on such fully
executed copy to SB.
Very truly yours,
SMITHKLINE XXXXXXX CORPORATION
By: /k/ Xxxxx Xxxxxx
-------------------------------------
Title: Senior VP, Business Development
----------------------------------
Date: 10/31/97
-----------------------------------
AGREED TO AND ACCEPTED:
NPS PHARMACEUTICALS, INC.
By: /k/ Xxxxxx Xxxxxxx
-----------------------
Title: CEO
--------------------
